Print Page     Close Window     

Download Mesoblast Corporate Backgrounder

Mesoblast Corporate Backgrounder (350 KB)

Mesoblast is a world leader in developing innovative cellular medicines.

The Company has established what it believes is the industry's most clinically advanced and diverse portfolio of cell-based product candidates ... More

Latest ASX AnnouncementsMore
13 December 2018
Meetings Held With FDA Support MSB's Planned GVHD Filing
05 December 2018
Response to ASX query
30 November 2018
Results of Meeting
30 November 2018
Presentation to 2018 Annual General Meeting
Upcoming EventsMore
There are currently no events scheduled.
Stock QuoteMore
Exchange :ASX
Price :A$1.14
Change : Stock is Down 0.06 (5.00%)
Volume :1,831,047
Data as of 14 December 2018 4:11 p.m. ET
Data provided by Nasdaq Minimum 15 minutes delay
Download Documentation First Quarter Results Presentation
Download Documentation 2018 Annual Report
Download Documentation Financial Results for the 2018 Full Financial Year, 4th Quarter Ended June 30, 2018
Download Documentation Financial Results for the Period Ended September 30, 2017
E-mail Alerts
Sign up to receive e-mail alerts.

Copyright © 2015 Mesoblast Inc.